Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous

NCT04947748 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-07-01

No results posted yet for this study

Summary

Short Post-operative Antibacterial Therapy in Complicated Appendicitis: Oral Versus Intravenous is a prospective randomized controlled trial comparing 24 hour intravenous antibacterial therapy to 24 hour oral antibacterial therapy after surgery in complicated appendicitis.

Conditions

  • Acute Appendicitis
  • Acute Appendicitis With Rupture
  • Acute Appendicitis Without Peritonitis
  • Acute Appendicitis With Appendix Abscess
  • Appendicitis; Perforation
  • Appendicitis Perforated
  • Appendicitis Acute

Interventions

OTHER

Oral versus intravenous administration of antibacterial treatment

Mode of administration of antibacterial treatment

Sponsors & Collaborators

  • Tartu University Hospital

    collaborator OTHER
  • North Estonia Medical Centre

    lead OTHER

Principal Investigators

  • Edgar Lipping, MD · North Estonia Medical Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Estonia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04947748 on ClinicalTrials.gov